Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb 4;5:135.
doi: 10.12688/f1000research.7847.1. eCollection 2016.

Publishing Confirming and Non-Confirming Data

Affiliations
Free PMC article

Publishing Confirming and Non-Confirming Data

Bruce Alberts et al. F1000Res. .
Free PMC article

Abstract

This editorial introduces the Preclinical Reproducibility and Robustness channel on F1000Research, which has been created to encourage and facilitate open and transparent publication and discussion of confirmatory and non-confirmatory studies in biomedical research.

Keywords: Amgen; Reproducibility; Robustness.

Conflict of interest statement

Competing interests: BA is an International Advisory Board member of F1000.

Similar articles

See all similar articles

References

    1. Begley CG, Ellis LM: Drug development: Raise standards for preclinical cancer research. Nature. 2012;483(7391):531–3. 10.1038/483531a - DOI - PubMed
    1. Prinz F, Schlange T, Asadullah K: Believe it or not: how much can we rely on published data on potential drug targets? Nat Rev Drug Discov. 2011;10(9):712. 10.1038/nrd3439-c1 - DOI - PubMed
    1. Ioannidis JP, Allison DB, Ball CA, et al. : Repeatability of published microarray gene expression analyses. Nat Genet. 2009;41(2):149–55. 10.1038/ng.295 - DOI - PubMed
    1. Bell AW, Deutsch EW, Au CE, et al. : A HUPO test sample study reveals common problems in mass spectrometry-based proteomics. Nat Methods. 2009;6(6):423–30. 10.1038/nmeth.1333 - DOI - PMC - PubMed
    1. Ioannidis JP: Why most published research findings are false. PLoS Med. 2005;2(8):e124. 10.1371/journal.pmed.0020124 - DOI - PMC - PubMed

Grant support

The author(s) declared that no grants were involved in supporting this work.

LinkOut - more resources

Feedback